NICE backs restricted use of Ondexxya
6th April 2021 Uncategorised 0Funding backed for reversal of gastrointestinal bleeds but not for intracranial haemorrhage More: NICE backs restricted use of Ondexxya Source: News
read moreFunding backed for reversal of gastrointestinal bleeds but not for intracranial haemorrhage More: NICE backs restricted use of Ondexxya Source: News
read moreThe drug offers new hope for epilepsy patients with focal-onset seizures More: EC approval for Ontozry Source: News
read moreThe parties intend to develop more cost-effective ways of producing biologic medicines More: Researchers link to facilitate cheaper biologics Source: News
read moreNHS England is rolling out Roche’s new combined treatment Phesgo, which drastically cuts administration time More: Thousands to benefit from five-minute breast cancer treatment Source: News
read more© 1994 - 2024 B.M. Pharmaceuticals